Ubs Group Ag Biote Corp. Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Biote Corp. stock. As of the latest transaction made, Ubs Group Ag holds 8,244 shares of BTMD stock, worth $42,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,244
Previous 13,000
36.58%
Holding current value
$42,951
Previous $75,000
18.67%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BTMD
# of Institutions
76Shares Held
15.9MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY3.77MShares$19.6 Million12.3% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$12.7 Million6.61% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$8.36 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$7.19 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.29MShares$6.69 Million0.05% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $39.5M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...